These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33739784)

  • 21. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry.
    Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A
    Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
    Lu D; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in Myelodysplastic Syndromes: Clinicopathologic Correlations and Immune Checkpoints.
    Hidalgo-López JE; Kanagal-Shamanna R; Quesada AE; Thakral B; Hu Z; Mitsuhashi T; Yabe M; Garcia-Manero G; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S16-S25. PubMed ID: 28760297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances of study on immunophenotyping of myelodysplastic syndromes-review].
    Qiao C; Fan L; Wu YJ; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1106-10. PubMed ID: 19698271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotypic analysis of myelodysplastic syndromes.
    Del Cañizo MC; Fernández ME; López A; Vidriales B; Villarón E; Arroyo JL; Ortuño F; Orfao A; San Miguel JF
    Haematologica; 2003 Apr; 88(4):402-7. PubMed ID: 12681967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia.
    Mashima K; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Umino K; Minakata D; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Ishihara Y; Ashizawa M; Yamamoto C; Fujiwara SI; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Ann Hematol; 2019 May; 98(5):1127-1133. PubMed ID: 30474718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival.
    Gupta P; Niehans GA; LeRoy SC; Gupta K; Morrison VA; Schultz C; Knapp DJ; Kratzke RA
    Leukemia; 1999 Jan; 13(1):44-53. PubMed ID: 10049059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic significance of morbidly hematopoietic characteristics in 69 patients with myelodysplastic syndrome].
    Wu YN; Luo ZB; Wang C; Li J; Luo HY; He DY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):150-4. PubMed ID: 25687064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunophenotypic Profile of CD34+ Subpopulations and Their Role in the Diagnosis and Prognosis of Patients with De-Novo, Particularly Low-Grade Myelodysplastic Syndromes.
    Gardikas N; Vikentiou M; Konsta E; Kontos CK; Papageorgiou SG; Spathis A; Bazani E; Bouchla A; Kapsimali V; Psarra K; Foukas P; Dimitriadis G; Pappa V
    Cytometry B Clin Cytom; 2019 Jan; 96(1):73-82. PubMed ID: 30334347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
    Mangi MH; Mufti GJ
    Blood; 1992 Jan; 79(1):198-205. PubMed ID: 1370203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell large granular lymphocyte proliferation in myelodysplastic syndromes: Clinicopathological features and prognostic significance.
    Zhang X; Sokol L; Bennett JM; Moscinski LC; List A; Zhang L
    Leuk Res; 2016 Apr; 43():18-23. PubMed ID: 26927701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphologic Spectrum of Lymphadenopathy in Adult-onset Immunodeficiency (Anti-interferon-γ Autoantibodies).
    Thingujam B; Syue LS; Wang RC; Chen CJ; Yu SC; Chen CC; Medeiros LJ; Liao IC; Tsai JW; Chang KC
    Am J Surg Pathol; 2021 Nov; 45(11):1561-1572. PubMed ID: 34010154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis.
    Maschek H; Kaloutsi V; Rodriguez-Kaiser M; Werner M; Choritz H; Mainzer K; Dietzfelbinger M; Georgii A
    Ann Hematol; 1993 Mar; 66(3):117-22. PubMed ID: 8471656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.
    Maftoun-Banankhah S; Maleki A; Karandikar NJ; Arbini AA; Fuda FS; Wang HY; Chen W
    Am J Clin Pathol; 2008 Feb; 129(2):300-8. PubMed ID: 18208811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome.
    Ogata K; Nakamura K; Yokose N; Tamura H; Tachibana M; Taniguchi O; Iwakiri R; Hayashi T; Sakamaki H; Murai Y; Tohyama K; Tomoyasu S; Nonaka Y; Mori M; Dan K; Yoshida Y
    Blood; 2002 Dec; 100(12):3887-96. PubMed ID: 12393641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
    Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
    Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
    Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
    Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
    Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
    Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased CD10-positive mature granulocytes in bone marrow from patients with myelodysplastic syndrome.
    Chang CC; Cleveland RP
    Arch Pathol Lab Med; 2000 Aug; 124(8):1152-6. PubMed ID: 10923075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myelodysplastic syndromes: pathophysiology, clinical and biological features].
    Becha M; Braham Jmili N
    Ann Biol Clin (Paris); 2015; 73(6):643-56. PubMed ID: 26635046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.